Welcome to our dedicated page for Lifevantage news (Ticker: LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage stock.
LifeVantage Corp (LFVN) delivers science-driven health solutions through nutrigenomic research and dietary supplements. This news hub provides investors and stakeholders with essential updates on corporate developments, product innovations, and market positioning in the nutraceutical industry.
Access timely regulatory filings, earnings reports, and press releases alongside analysis of scientific advancements. Our curated collection includes updates on weight management systems, cognitive enhancement products, and dermatological solutions backed by gene expression research.
Key content categories cover financial performance metrics, research partnerships, product launch details, and corporate governance updates. Bookmark this page for streamlined access to verified information supporting informed decisions about LFVN's market activities.
LifeVantage (Nasdaq: LFVN), a prominent health and wellness company, has announced a quarterly cash dividend of $0.04 per share of common stock. The dividend will be paid on September 17, 2024, to stockholders of record at the close of business on September 9, 2024. LifeVantage specializes in products designed to activate optimal health processes at the cellular level. This dividend declaration demonstrates the company's commitment to returning value to its shareholders and may indicate confidence in its financial stability and future prospects.
LifeVantage (Nasdaq: LFVN) reported financial results for Q4 and fiscal year 2024. Key highlights:
- Q4 revenue: $48.9 million, down 9.8% YoY
- FY2024 revenue: $200.2 million, down 6.2% YoY
- Q4 net income per diluted share: $0.10, down from $0.15 YoY
- FY2024 net income per diluted share: $0.23, up from $0.20 YoY
- FY2024 adjusted EBITDA: $17.0 million, up 44.7% YoY
- Strong balance sheet with $16.9 million cash and no debt
The company declared a cash dividend of $0.04 per share. For FY2025, LifeVantage projects revenue of $200-210 million, adjusted EBITDA of $18-21 million, and adjusted EPS of $0.70-$0.80.
LifeVantage (Nasdaq: LFVN) has announced the appointment of Rajendran Anbalagan to its Board of Directors, effective immediately. This strategic move follows a comprehensive search for a candidate with transformational digital skills. Mr. Anbalagan brings extensive technology experience and a deep understanding of leveraging digital tools for operational excellence.
Simultaneously, Erin Brockovich has resigned from the Board after five years of service to make room for Mr. Anbalagan. The company expressed gratitude for Ms. Brockovich's contributions, citing her diverse legal and business background and renowned advocacy experience as valuable assets during her tenure.
LifeVantage (Nasdaq: LFVN) recently hosted its exclusive Rise Retreat in Park City, UT, from August 22-25, 2024. The event brought together top enrolling Independent Consultants for a weekend of leisure, adventure, and strategic collaboration. Attendees received an exclusive preview of LifeVantage's innovative weight management products, set to launch in October. These products are designed to activate natural production of the GLP-1 hormone, reduce food noise, and support healthy weight goals.
Consultants who earned the trip were given the opportunity to try the new weight management system ahead of its official launch. The retreat encouraged collaboration, with participants brainstorming strategies to build excitement over the next six weeks. The full details of the new products will be unveiled at Market Connect in Kansas City, MO, on October 11-12, 2024.
LifeVantage (Nasdaq: LFVN), a health and wellness company, has announced it will release its fourth quarter and full fiscal year 2024 financial results on August 28, 2024, after the stock market closes. The company will host a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on the same day.
Investors can participate in the live call by dialing (877) 704-4453 from the U.S. or (201) 389-0920 internationally. A telephone replay will be available until September 11, 2024. Additionally, a live webcast will be accessible on the company's Investor Relations website, with an archive available for approximately 30 days.
LifeVantage (Nasdaq: LFVN) has announced a significant update to its Rewards Circle Customer loyalty program in the U.S., Australia, and New Zealand markets. The refresh introduces new benefits for both Consultants and Customers, aiming to enhance engagement and provide greater value. Consultants will now enjoy free shipping on enrollment orders with scheduled future Subscriptions and receive business-building rewards for each Subscription shipment. Customers will benefit from first-Subscription perks, including free shipping and gifts for orders above a certain threshold, as well as lower redemption thresholds for Reward Credits.
This update comes 16 months after the program's initial launch in March 2023 as part of LifeVantage's LV360 initiatives. The enhancements were driven by Customer retention data and aim to make Subscriptions more attractive for Consultants looking to grow their business.
LifeVantage (Nasdaq: LFVN) is hosting virtual 'LifeVantage Open House' calls on July 23 and 24, 2024, to showcase its recent transformation initiatives, innovative compensation plan, and award-winning products. The July 23 call will feature a Q&A with company executives, including CEO Steve Fife, and board member Erin Brockovich. They will discuss the company's evolution and positioning for future growth in direct sales.
The July 24 call will highlight experiences of LifeVantage sales leaders, including members of the Field and Scientific Advisory Boards. They will share insights on the company's products, the Evolve Compensation Plan, and why it's an exciting time to be a LifeVantage Consultant. Both calls are scheduled for 6:00 PM MT and are open to anyone interested in learning more about LifeVantage's health and wellness offerings and business opportunities.
LifeVantage (Nasdaq: LFVN) hosted its global Activate 2024 virtual event on July 20, 2024, reaffirming its commitment to the direct selling industry. The event highlighted the company's transformation and focus on modern direct selling through its LV360 initiative. CEO Steve Fife teased a major product launch set for October 2024 - an innovative weight loss product designed to suppress food cravings and balance hunger hormones through cellular activation.
The event emphasized the company's Rise ERA strategy (Enrolling, Retaining, and Advancing), showcasing positive impacts on Consultant performance. LifeVantage also announced its 2024 Incentive Trip - an 8-day Alaskan cruise for top achievers from the US, Canada, Mexico, and Europe. The event included comprehensive sales training sessions led by top leaders, providing strategies aligned with Rise ERA principles.
LifeVantage (Nasdaq: LFVN) announced that its President and CEO, Steve Fife, and CFO, Carl Aure, will participate in two investor conferences in June 2024. They will present at the Water Tower Research Consumer Products Virtual Investor Conference on June 5 at 11:00 am ET, and the MicroCap Rodeo – Spring Into Summer Conference on June 6 at 2:00 pm ET in New York City. Both presentations will be available via live webcast and for replay on LifeVantage’s Investor Relations website for approximately 90 days.
LifeVantage (LFVN) will participate in the Sidoti Micro Cap Conference on May 8-9, 2024. The President, CEO, and CFO will present to investors. The webcast will be available on the company's Investor Relations website.
FAQ
What is the current stock price of Lifevantage (LFVN)?
What is the market cap of Lifevantage (LFVN)?
